Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
During the Super Bowl, telehealth platform Hims & Hers released a controversial ad calling out drugmakers that provide weight loss drugs priced for profits, not patients. It then proceeded to highlight its compounded GLP-1 offerings, calling them affordable, doctor-trusted and formulated in the USA. Shortly after, Novo Nordisk responded to the ad with its own Check before you inject campaign, highlighting the argument that patients should be wary of compounded GLP-1s given that they arent FDA-approved products
Despite rising overall spending, patients generally paid less out of pocket
Never share pens or needles with others
Med Clnica
And its hard to stay on a strict plan like this one long-term. Claim 3: It stabilizes blood sugar The body breaks down carbohydrates from food into glucose for energy
The insurer said in a statement to Fierce Healthcare that it will no longer cover GLP-1s in its large group fully insured plans as of Jan
US$ 24.45
US$ 28.24
US$ 25.73
US$ 26.07
US$ 28.60
US$ 24.70
US$ 22.89
US$ 22.69
